JP Morgan Chase
ELOX

JP Morgan Chase’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

JP Morgan Chase’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$5 – 8103
2023
Q3 		$5 Hold
1
– – ﹤0.01% 7369
2023
Q2 		$4 Hold
1
– – ﹤0.01% 6843
2023
Q1 		$0 Hold
1
– – ﹤0.01% 7548
2022
Q4 		$0 Sell
1
-1
-50% -$5 ﹤0.01% 7323
2022
Q3 		$0 Buy
2
+1
+100% +$12 ﹤0.01% 7101
2022
Q2 		$0 Sell
1
-15
-94% -$207 ﹤0.01% 7151
2022
Q1 		$0 Buy
16
+15
+1,500% +$295 ﹤0.01% 7241
2021
Q4 		$0 Hold
1
– – ﹤0.01% 7175
2021
Q3 		$0 Sell
1
-32
-97% -$1.97K ﹤0.01% 6979
2021
Q2 		$3K Sell
33
-1,770
-98% -$148K ﹤0.01% 6192
2021
Q1 		$239K Buy
1,803
+60
+3% +$9.17K ﹤0.01% 5074
2020
Q4 		$278K Buy
1,743
+1,494
+600% +$183K ﹤0.01% 4687
2020
Q3 		$25K Buy
249
+24
+11% +$2.88K ﹤0.01% 5109
2020
Q2 		$27K Buy
225
+23
+11% +$2.6K ﹤0.01% 4984
2020
Q1 		$16K Sell
202
-5
-2% -$814 ﹤0.01% 4995
2019
Q4 		$61K Buy
207
+1
+0.5% +$202 ﹤0.01% 5063
2019
Q3 		$37K Buy
206
+50
+32% +$14.2K ﹤0.01% 5273
2019
Q2 		$62K Buy
156
+19
+14% +$8K ﹤0.01% 5094
2019
Q1 		$64K Sell
137
-6
-4% -$2.92K ﹤0.01% 5044
2018
Q4 		$69K Buy
143
+13
+10% +$7.17K ﹤0.01% 4979
2018
Q3 		$89K Buy
130
+5
+4% +$3.2K ﹤0.01% 4995
2018
Q2 		$86K Buy
+125
New +$81K ﹤0.01% 4893

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

JP Morgan Chase's ELOX Position: Q4 2023 in Review

JP Morgan Chase sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 1 share — an estimated $5 sold.

JP Morgan Chase first reported a position in ELOX in Q2 2018 and held it in 22 quarters. The position peaked at $278K in Q4 2020. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

  • JP Morgan Chase reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • JP Morgan Chase sold 1 Eloxx Pharmaceuticals, Inc. Common Stock share in Q4 2023, an estimated $5.
  • JP Morgan Chase first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 22 quarters.
  • JP Morgan Chase's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $278K in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.